Pharmachal sat down with Michael van Cuylenburg, Director of the Ricard Group to talk about the company, its technology and its pathway towards a stock market listing.
top of page
Recent PostsSee All
Rationale for a New Outpatient Drug Therapy Algorithm in COVID-19 Patients Based on the Principle of
Introduction The urgency of the COVID-19 problem (CoronaVirus Disease 2019) is currently beyond doubt. In Russia alone, more than 4.5 million people have suffered from this disease, more than 100,000
bottom of page